This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Genpact (G) Stock up 1.6% Since Q2 Earnings: Here's Why
by Zacks Equity Research
Genpact's (G) stock has been rising since it reported second-quarter 2020 results, which reflect better-than-expected top- and bottom-line performances.
Genpact (G) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Genpact (G) delivered earnings and revenue surprises of 48.57% and 7.37%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Genpact (G) Q2 Earnings Expected to Decline
by Zacks Equity Research
Genpact (G) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Genpact (G) Up 8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Genpact (G) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Retain Genpact (G) in Your Portfolio
by Zacks Equity Research
Genpact (G) is currently benefiting from a strong customer base and accretive acquisitions.
Genpact (G) Beats Q1 Earnings Estimate Amid Coronavirus Crisis
by Zacks Equity Research
Genpact's (G) first-quarter 2020 earnings and revenues increase year over year.
Genpact (G) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Genpact (G) delivered earnings and revenue surprises of 15.22% and 3.88%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
ATTO or G: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ATTO vs. G: Which Stock Is the Better Value Option?
Here's Why Investors Should Hold on to MAXIMUS (MMS) Stock
by Zacks Equity Research
Long-term contracts provide MAXIMUS (MMS) predictable recurring revenue streams.
Here's Why You Should Hold on to Rollins (ROL) Stock Now
by Zacks Equity Research
Rollins' (ROL) top line benefits from a balanced approach to organic and inorganic growth. However, rising expenses put pressure on the bottom line
Accenture Snaps Up Yesler to Boost B2B Marketing Services
by Zacks Equity Research
The buyout enables Accenture (ACN) to bolster its account-based marketing, sales enablement, customer advocacy and marketing automation offerings.
Booz Allen Unveils Resilience Program to Combat Coronavirus
by Zacks Equity Research
The program aims at enhancing employment security and benefits that Booz Allen (BAH) offers.
FactSet (FDS) Beats Q2 Earnings Estimates, Lags Revenues
by Zacks Equity Research
FactSet's (FDS) second-quarter fiscal 2020 results benefit from higher sales of analytics, wealth management, content and technology solutions, and lower tax rate.
US Ecology Strengthens Cash Position Amid Coronavirus Crisis
by Zacks Equity Research
US Ecology (ECOL) announces steps to counter the adverse financial impacts of the coronavirus pandemic.
Envestnet Picks CEO, President, Board Chairman & Vice Chairman
by Zacks Equity Research
These appointments seem to be part of Envestnet's (ENV) efforts to enhance employee skills and improve offerings.
Paychex Unveils Support Plans for SMBs Amid Coronavirus Crisis
by Zacks Equity Research
Paychex's (PAYX) compliance support is aimed at enabling businesses manage provision of the Families First Coronavirus Response Act and CARES Act.
6 Reasons Why You Should Buy S&P Global (SPGI) Stock Now
by Zacks Equity Research
S&P Global (SPGI) looks strong on the back of strategic acquisitions, which have helped it innovate, increase differentiated content and develop new products.
Rollins (ROL) Raises Paid Time Off Amid Coronavirus Outbreak
by Zacks Equity Research
Rollins (ROL) is currently offering 80 hours of PTO to full-time employees and 40 hours to part-time employees for emergency leave.
Insperity Forms Support Team for SMBs Amid Coronavirus Crisis
by Zacks Equity Research
Insperity (NSP) remains fully operational amid the coronavirus pandemic, leveraging on its well-established business continuity plan that succeeded during Hurricane Harvey in 2017.
Here's Why You Should Hold on to Waste Management (WM) Now
by Zacks Equity Research
Waste Management's (WM) core operating and cost-cut initiatives, along with shareholder-friendly measures are aiding growth. However, its high debt levels are worrisome.
Rollins' Orkin Starts Disinfection Service Amid Coronavirus Scare
by Zacks Equity Research
Rollins' (ROL) move makes sense as public health concerns are increasing across the world amid the coronavirus pandemic.
Stericycle (SRCL) Hits a New 52-Week Low: What's Ailing It?
by Zacks Equity Research
Consecutive lower-than-expected top-line performance, declining CRS businesses and foreign currency exchange rate fluctuations are weighing on Stericycle (SRCL) stock.
Here's Why You Should Invest in Omnicom (OMC) Stock Now
by Zacks Equity Research
Consistency and diversity of operations, as well as consumer-centric business solutions ensure Omnicom's (OMC) uninterrupted profitability. Its shareholder-friendly measures are also impressive
Paychex (PAYX) Q3 Earnings & Revenues Surpass Estimates
by Zacks Equity Research
Paychex (PAYX) third-quarter fiscal 2020 earnings and revenues increase on a year-over-year basis.
Aptiv (APTV) Reinforces Cash Position Amid Coronavirus Crisis
by Zacks Equity Research
Aptiv (APTV) announces steps to counter the negative financial impacts of coronavirus pandemic.